financetom
Business
financetom
/
Business
/
Apple sharply cuts back on Vision Pro production, The Information reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple sharply cuts back on Vision Pro production, The Information reports
Oct 23, 2024 8:29 AM

Oct 23 (Reuters) - Apple ( AAPL ) has sharply scaled

back its Vision Pro production since early summer and could stop

making the existing version of the mixed reality headset by

year-end, the Information reported on Wednesday, citing people

involved in building its components.

Sales for the device have been waning after initial

enthusiasm following its launch in February, due to the

headset's hefty price tag and competition from cheaper options

including Meta Platforms' ( META ) Quest.

While Apple's ( AAPL ) Vision Pro starts at around $3,500 in the

U.S., Meta's Quest 3 headset has a price tag of around $500.

According to the Information report, employees at three

Vision Pro suppliers have so far built enough components to make

between 500,000 and 600,000 headsets. One of the employees said

their factory suspended production of Vision Pro components in

May.

Apple ( AAPL ) in recent weeks has also told the device's assembler,

Luxshare, that it might need to wind down its manufacturing in

November, the report said, citing an employee at the

manufacturer.

The iPhone maker did not immediately respond to a Reuters

request for comment.

The Information had reported in June that Apple ( AAPL ) was working

on releasing a more affordable Vision product with fewer

features before the end of 2025 and suspended work on its next

high-end headset.

Apple ( AAPL ) launched the Vision Pro in international markets

earlier this year to reinvigorate demand at a time when it

rushes to incorporate artificial intelligence into its flagship

mobile devices to get ahead of rivals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft's AI edge under scrutiny as OpenAI turns to rivals for cloud services
Microsoft's AI edge under scrutiny as OpenAI turns to rivals for cloud services
Jul 29, 2025
By Aditya Soni (Reuters) -Microsoft investors head into Wednesday's earnings with one big question: is the company's artificial intelligence edge at risk as partner OpenAI turns to rivals Google, Oracle and CoreWeave for cloud services? Exclusive licensing deals and access to OpenAI's cutting-edge models have made Microsoft one of the biggest winners of the generative AI boom, fueling growth in...
Civeo Q2 revenue just shy of estimates, keeps FY outlook
Civeo Q2 revenue just shy of estimates, keeps FY outlook
Jul 29, 2025
Overview * Civeo ( CVEO ) Q2 revenue of $162.7 mln missed analyst expectations * Company reports Q2 net loss of $3.3 mln, contrasting last year's profit * Co repurchased 883,000 shares, about 7% of total shares outstanding in Q2 Outlook * Civeo ( CVEO ) maintains 2025 revenue guidance of $640 mln to $670 mln * Company maintains 2025...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Genetic testing firm GeneDx beats Q2 adjusted EPS estimates, raises full-year guidance
Genetic testing firm GeneDx beats Q2 adjusted EPS estimates, raises full-year guidance
Jul 29, 2025
Overview * GeneDx Q2 2025 revenue rises 49% yr/yr to $102.7 mln * Adjusted EPS beats analyst expectations, per LSEG data * Co raises full-year revenue guidance to $400-$415 mln Outlook * GeneDx ( WGS ) raises 2025 revenue guidance to $400-$415 mln * Company expects 48%-52% growth in exome and genome revenue * GeneDx ( WGS ) anticipates 68%-71%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved